InvestorsHub Logo
icon url

doogdilinger

04/05/18 9:08 AM

#34037 RE: fabius #34035

I remember arguing with people here about my own personal SeroquelXR/MNK expectations foolishly believing that the 2 analyst projections/expectations meant that we were gonna have a very successful SeroquelXR commercialization.

However upon launch by MNK I quickly realized how wrong I was and have been eating humble pie ever since.

It's appalling how pathetic SeroquelXR sales remain to be and quite frankly I find myself hoping that the ongoing lack of FDA approvals on both Pristiq and Lamictal result in MNK kicking both those licensing agreements with IPCI to the curb.

I'm already furious about the Keppra and Glucophage FDA approved ANDA's sitting on a shelf collecting dust...but it's even more disappointing watching MNK make a total and complete mockery of SeroquelXR commercialization to the point that the deal actually creates a gigantic negative for IPCI instead of the extreme positive most thought it was/was going to be when the deal was 1st announced way back in October 2016.
icon url

wimuskyfisherman

04/05/18 10:00 AM

#34041 RE: fabius #34035

Fabius- Agreed... The more and more I watch them continuously flounder... And make the same mistakes over and over... And not listen to anyone's advice... I see arrogance too...